141 related articles for article (PubMed ID: 30044210)
21. Regulation of ERK1 gene expression by coactivator proteins.
Chu BY; Tran K; Ku TK; Crowe DL
Biochem J; 2005 Dec; 392(Pt 3):589-99. PubMed ID: 16050810
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the homeodomain CCAAT displacement/cut protein function by histone acetyltransferases p300/CREB-binding protein (CBP)-associated factor and CBP.
Li S; Aufiero B; Schiltz RL; Walsh MJ
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7166-71. PubMed ID: 10852958
[TBL] [Abstract][Full Text] [Related]
23. Autoacetylation induced specific structural changes in histone acetyltransferase domain of p300: probed by surface enhanced Raman spectroscopy.
Arif M; Kumar GV; Narayana C; Kundu TK
J Phys Chem B; 2007 Oct; 111(41):11877-9. PubMed ID: 17894486
[TBL] [Abstract][Full Text] [Related]
24. A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice.
Chatterjee S; Mizar P; Cassel R; Neidl R; Selvi BR; Mohankrishna DV; Vedamurthy BM; Schneider A; Bousiges O; Mathis C; Cassel JC; Eswaramoorthy M; Kundu TK; Boutillier AL
J Neurosci; 2013 Jun; 33(26):10698-712. PubMed ID: 23804093
[TBL] [Abstract][Full Text] [Related]
25. Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells.
Koutsogiannouli EA; Wagner N; Hader C; Pinkerneil M; Hoffmann MJ; Schulz WA
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678170
[TBL] [Abstract][Full Text] [Related]
26. Acetyltransferases CBP/p300 Control Transcriptional Switch of β-Catenin and Stat1 Promoting Osteoblast Differentiation.
Zhang L; Zhu K; Xu J; Chen X; Sheng C; Zhang D; Yang Y; Sun L; Zhao H; Wang X; Tao B; Zhou L; Liu J
J Bone Miner Res; 2023 Dec; 38(12):1885-1899. PubMed ID: 37850815
[TBL] [Abstract][Full Text] [Related]
27. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity.
Chakravarti D; Ogryzko V; Kao HY; Nash A; Chen H; Nakatani Y; Evans RM
Cell; 1999 Feb; 96(3):393-403. PubMed ID: 10025405
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of PCAF by anacardic acid derivative leads to apoptosis and breaks resistance to DNA damage in BCR-ABL-expressing cells.
Kusio-Kobialka M; Dudka-Ruszkowska W; Ghizzoni M; Dekker FJ; Piwocka K
Anticancer Agents Med Chem; 2013 Jun; 13(5):762-7. PubMed ID: 23157591
[TBL] [Abstract][Full Text] [Related]
29. Current development of CBP/p300 inhibitors in the last decade.
He ZX; Wei BF; Zhang X; Gong YP; Ma LY; Zhao W
Eur J Med Chem; 2021 Jan; 209():112861. PubMed ID: 33045661
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation.
Stiehl DP; Fath DM; Liang D; Jiang Y; Sang N
Cancer Res; 2007 Mar; 67(5):2256-2264. PubMed ID: 17332356
[TBL] [Abstract][Full Text] [Related]
31. p300/CBP-associated factor histone acetyltransferase processing of a peptide substrate. Kinetic analysis of the catalytic mechanism.
Lau OD; Courtney AD; Vassilev A; Marzilli LA; Cotter RJ; Nakatani Y; Cole PA
J Biol Chem; 2000 Jul; 275(29):21953-9. PubMed ID: 10777508
[TBL] [Abstract][Full Text] [Related]
32. CBP/p300 is a cell type-specific modulator of CLOCK/BMAL1-mediated transcription.
Hosoda H; Kato K; Asano H; Ito M; Kato H; Iwamoto T; Suzuki A; Masushige S; Kida S
Mol Brain; 2009 Nov; 2():34. PubMed ID: 19922678
[TBL] [Abstract][Full Text] [Related]
33. Role of the CBP catalytic core in intramolecular SUMOylation and control of histone H3 acetylation.
Park S; Stanfield RL; Martinez-Yamout MA; Dyson HJ; Wilson IA; Wright PE
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5335-E5342. PubMed ID: 28630323
[TBL] [Abstract][Full Text] [Related]
34. Functional interplay between CBP and PCAF in acetylation and regulation of transcription factor KLF13 activity.
Song CZ; Keller K; Chen Y; Stamatoyannopoulos G
J Mol Biol; 2003 May; 329(2):207-15. PubMed ID: 12758070
[TBL] [Abstract][Full Text] [Related]
35. The histone acetylase activator pentadecylidenemalonate 1b rescues proliferation and differentiation in the human cardiac mesenchymal cells of type 2 diabetic patients.
Vecellio M; Spallotta F; Nanni S; Colussi C; Cencioni C; Derlet A; Bassetti B; Tilenni M; Carena MC; Farsetti A; Sbardella G; Castellano S; Mai A; Martelli F; Pompilio G; Capogrossi MC; Rossini A; Dimmeler S; Zeiher A; Gaetano C
Diabetes; 2014 Jun; 63(6):2132-47. PubMed ID: 24458358
[TBL] [Abstract][Full Text] [Related]
36. Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe.
Humphreys PG; Bamborough P; Chung CW; Craggs PD; Gordon L; Grandi P; Hayhow TG; Hussain J; Jones KL; Lindon M; Michon AM; Renaux JF; Suckling CJ; Tough DF; Prinjha RK
J Med Chem; 2017 Jan; 60(2):695-709. PubMed ID: 28002667
[TBL] [Abstract][Full Text] [Related]
37. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
38. Distinct embryonic expression and localization of CBP and p300 histone acetyltransferases at the mouse alphaA-crystallin locus in lens.
Yang Y; Wolf LV; Cvekl A
J Mol Biol; 2007 Jun; 369(4):917-26. PubMed ID: 17467007
[TBL] [Abstract][Full Text] [Related]
39. The transcriptional coactivators p300 and CBP are histone acetyltransferases.
Ogryzko VV; Schiltz RL; Russanova V; Howard BH; Nakatani Y
Cell; 1996 Nov; 87(5):953-9. PubMed ID: 8945521
[TBL] [Abstract][Full Text] [Related]
40. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
Bordonaro M; Lazarova DL
World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
